Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing

por Devarakonda, Krishna, Vandenbossche, Joris, Richarz, Ute
Publicado 2013

Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre study

por Le Loët, Xavier, Pavelka, Karel, Richarz, Ute
Publicado 2005

Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS(®) hydromorphone ER) in patients with chronic pain

por Vandenbossche, Joris, Richarz, Ute, Richards, Henry M
Publicado 2012

Galantamine versus donepezil in Chinese patients with Alzheimer’s disease: results from a randomized, double-blind study

por Zhang, Zhenxin, Yu, Lu, Gaudig, Maren, Schäuble, Barbara, Richarz, Ute
Publicado 2012

Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine

por Kalso, Eija, Simpson, Karen H, Slappendel, Robert, Dejonckheere, Joachim, Richarz, Ute
Publicado 2007

A Phase IIIb, Multicentre, Randomised, Parallel-Group, Placebo-Controlled, Double-Blind Study to Investigate the Efficacy and Safety of OROS Hydromorphone in Subjects with Moderate...

por Vojtaššák, Jozef, Vojtaššák, Jozef, Jacobs, Adam, Rynn, Leonie, Waechter, Sandra, Richarz, Ute
Publicado 2011

Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe

por Fife, Daniel, Waller, John, Kaplan, Sigal, Hu, Peter, Phillips, Syd, Oliveria, Susan A., Richarz, Ute
Publicado 2019

Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophre...

por Turkoz, Ibrahim, Wong, Joshua, Chee, Benjamin, Siddiqui, Uzma, Knight, R. Karl, Richarz, Ute, Correll, Christoph U.
Publicado 2023

Long-Term Efficacy and Safety of Paliperidone 6-Month Formulation: An Open-Label 2-Year Extension of a 1-Year Double-Blind Study in Adult Participants With Schizophrenia

por Najarian, Dean, Turkoz, Ibrahim, Knight, R Karl, Galderisi, Silvana, Lamaison, Hector F, Zalitacz, Piotr, Aravind, Suresh, Richarz, Ute
Publicado 2023

The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia

por Milz, Ruth, Benson, Carmela, Knight, Karl, Antunes, Jose, Najarian, Dean, Lopez Rengel, Paola-Maria, Wang, Steven, Richarz, Ute, Gopal, Srihari, Kane, John M
Publicado 2023

Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a...

por Giron‐Hernandez, Cesar, Han, Joong Hee, Alberio, Roberta, Singh, Arun, García-Portilla, Maria Paz, Pompili, Maurizio, Knight, R Karl, Richarz, Ute, Gopal, Srihari, Antunes, José
Publicado 2023

Efficacy and safety of paliperidone palmitate 6-monthly long-acting injectable in reduction of relapses in patients with schizophrenia: An Asian subgroup analysis of phase 3, rando...

por Richarz, Ute, Han, John, Bai, Ya-Mei, Yu-Hai Chen, Eric, Chung, Young Chul, Jhanwar, Venu Gopal, Kim, Sung-Wan, Sulaiman, Ahmad Hatim, Knight, Karl, Gopal, Srihari
Publicado 2023

Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study: Treatment pa...

por He, Jianming, Schmerold, Luke, Van Rampelbergh, Rian, Qiu, Lugui, Potluri, Ravi, Dasgupta, Anandaroop, Li, Lin, Li, Yunan, Hu, Peter, Nemat, Sepideh, Smugar, Steven S., Zeltzer, Paul, Appiani, Carlos, Li, Qing, Mehra, Maneesha, Richarz, Ute
Publicado 2020